NAD+ — a central coenzyme in research on cell metabolism

NAD+ (nicotinamide adenine dinucleotide) is one of the most important coenzymes in biochemistry — a molecule present in every living cell, from bacteria to humans. It occurs in two interconvertible forms: oxidized (NAD+) and reduced (NADH), which continuously cycle between one another, carrying electrons in metabolic reactions. This is precisely what makes NAD+ a subject of intensive basic research: it combines two roles at once — a classic electron carrier and a substrate consumed by an entire family of regulatory enzymes.

An additional reason for scientific interest is the observation that the concentration of NAD+ in tissues declines with the age of the organism — a documented biological fact in animal models and in some human tissues. This has opened a broad field of research on NAD+ metabolism and its precursors, although — as we show below — the interpretation of these data remains cautious.

Mechanism in brief

At the heart of NAD+ action lies a redox reaction: the NAD+ form accepts electrons (together with a proton), transforming into NADH, and then releases them in the respiratory chain. On a lock-and-key basis, however, NAD+ also fits into the active sites of enzymes that consume it, rather than merely transforming it: sirtuins (SIRT1–SIRT7), poly-ADP-ribose polymerases (PARP) and hydrolases such as CD38. This dual function — an exchangeable cofactor and a consumed substrate — is the key to why biochemists regard NAD+ as a node connecting energy metabolism with cell regulation.

What is being studied

• Energy metabolism — in vitro and in biochemical studies the NAD+/NADH pair has been described as the central electron carrier in glycolysis, the Krebs cycle and oxidative phosphorylation; it is a subject of research on the energy balance of mitochondria.
• Sirtuin function — in cellular and animal models, sirtuins are studied as NAD+-dependent enzymes involved in protein deacetylation and the regulation of gene expression; NAD+ availability is considered here as a factor modulating their activity.
• DNA repair — in vitro and in cell lines, PARP enzymes use NAD+ as a substrate in the response to DNA damage; the relationship between the size of the NAD+ pool and the efficiency of these pathways is being investigated.
• Decline of NAD+ with age and precursors — in animal models, the salvage pathway and the precursors NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are analyzed as routes for replenishing the NAD+ pool; this is an area of active but still inconclusive preclinical research.

Origin and historical context

The history of NAD+ dates back to 1906, when Arthur Harden and William Young described in yeast extracts a heat-stable factor that accelerated fermentation — then named "cozymase." In the following decades Hans von Euler-Chelpin established its structure, and Otto Warburg explained the role of the dinucleotide as a hydrogen carrier in redox reactions — work honored many times with Nobel Prizes. A renaissance of interest came at the turn of the 20th and 21st centuries, when teams studying sirtuins (including those around Leonard Guarente) and precursor metabolism (research on NR and NMN conducted by, among others, Charles Brenner and Shin-ichiro Imai) showed that NAD+ is not only a redox coenzyme but also a signaling substrate. This combination of classic biochemistry with regulatory biology has made NAD+ one of the most frequently studied compounds in the metabolic sciences.

Research specification

In a laboratory context, NAD+ is usually supplied in the form of a lyophilisate (powder), which supports stability during transport and storage. The research material is stored in accordance with the recommendations for reagents — cold, protected from moisture and light — and the details are provided in the product documentation. The quality standard is a purity determination by HPLC and the provision of a certificate of analysis (COA). The physicochemical and identification parameters are described in the safety data sheets. All of this information pertains exclusively to research applications and does not constitute any health promise.

Level of evidence

The role of NAD+ in redox reactions is one of the best-documented facts of biochemistry — here the level of evidence is very high and has been confirmed many times. The translation of the hypothesis that "raising the level of NAD+ brings benefit" into hard conclusions, however, looks quite different. Although the decline of NAD+ with age is observed, the simple scheme "more NAD+ = longer life" is today questioned by part of the literature: more recent preclinical data point to complexity (including a differentiated role of NAD+ metabolism in various cell types, potentially undesirable in some cases). Human data concerning precursors are limited and inconclusive. The honest state of knowledge is: a well-understood biochemical mechanism, promising but unresolved regulatory hypotheses, and a clear "requires further research" with respect to the effects of manipulating the NAD+ pool.

For research purposes only. Not for consumption by humans or animals.